BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 36625807)

  • 1. Autism Spectrum Disorder: A Review.
    Hirota T; King BH
    JAMA; 2023 Jan; 329(2):157-168. PubMed ID: 36625807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
    Casseus M; Kim WJ; Horton DB
    Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014.
    Christensen DL; Maenner MJ; Bilder D; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Pettygrove SD; Robinson C; Shenouda J; White T; Zahorodny W; Pazol K; Dietz P
    MMWR Surveill Summ; 2019 Apr; 68(2):1-19. PubMed ID: 30973853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
    Anagnostou E
    Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
    Baio J; Wiggins L; Christensen DL; Maenner MJ; Daniels J; Warren Z; Kurzius-Spencer M; Zahorodny W; Robinson Rosenberg C; White T; Durkin MS; Imm P; Nikolaou L; Yeargin-Allsopp M; Lee LC; Harrington R; Lopez M; Fitzgerald RT; Hewitt A; Pettygrove S; Constantino JN; Vehorn A; Shenouda J; Hall-Lande J; Van Naarden Braun K; Dowling NF
    MMWR Surveill Summ; 2018 Apr; 67(6):1-23. PubMed ID: 29701730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurring attention-deficit/hyperactivity disorder and anxiety disorders differentially affect males and females with autism.
    Wodka EL; Parish-Morris J; Annett RD; Carpenter L; Dillon E; Michaelson J; Kim SH; Landa R; ; Kanne S
    Clin Neuropsychol; 2022 Jul; 36(5):1069-1093. PubMed ID: 34315336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M; Erickson CA
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.
    Christensen DL; Braun KVN; Baio J; Bilder D; Charles J; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Lee LC; Pettygrove S; Robinson C; Schulz E; Wells C; Wingate MS; Zahorodny W; Yeargin-Allsopp M
    MMWR Surveill Summ; 2018 Nov; 65(13):1-23. PubMed ID: 30439868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.
    Christensen DL; Baio J; Van Naarden Braun K; Bilder D; Charles J; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Lee LC; Pettygrove S; Robinson C; Schulz E; Wells C; Wingate MS; Zahorodny W; Yeargin-Allsopp M;
    MMWR Surveill Summ; 2016 Apr; 65(3):1-23. PubMed ID: 27031587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder.
    Hyman SL; Levy SE; Myers SM;
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31843864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
    Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
    JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2016.
    Shaw KA; Maenner MJ; Baio J; ; Washington A; Christensen DL; Wiggins LD; Pettygrove S; Andrews JG; White T; Rosenberg CR; Constantino JN; Fitzgerald RT; Zahorodny W; Shenouda J; Daniels JL; Salinas A; Durkin MS; Dietz PM
    MMWR Surveill Summ; 2020 Mar; 69(3):1-11. PubMed ID: 32214075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.